BioSpace News Archive

The Procter & Gamble Company (NYSE:PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.

Sofinnova Partners announced today it has led Inventiva Pharma (IVA) €35,5 M capital increase through its newly created Sofinnova Crossover I Fund.

Royal Philips is showcasing its integrated radiation oncology solutions in the exhibition at the European Society for Radiation Oncology’s (ESTRO) 37th Annual Meeting in Barcelona, Spain.

Biohaven Pharmaceutical Holding Company Ltd. announced today that it will hold an investor event concurrently with the 2018 American Academy of Neurology (AAN) Annual Meeting in Los Angeles, from 6:00 p.m. to 7:30 p.m. PT on Sunday, April 22, 2018.

Helperby also presented preclinical data which shows that AZT is active against carbapenem and colistin resistant Enterobacteriaceae. AZT is a DNA chain terminator and represents a new class of antibacterial agent against the most resistant Gram-negative bacteria. Further data were presented showing the combination to be active in animal models.

Moberg Pharma AB announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company part-time as Senior Adviser.

On 26 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2018.

OBI Pharma, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase I/II study of OBI-3424, a first-in-class DNA alkylating agent that targets cancers that overexpress the aldo-keto reductase 1C3 (AKR1C3) enzyme.

Harborview Farms is launching today as the latest Bayer ForwardFarm - the first in North America.

For the third consecutive year, Joule, a subsidiary of the Canadian Medical Association (CMA), is providing grant funding to drive physician-led innovation.